Previous 10 | Next 10 |
home / stock / ortif / ortif news
Ortho Regenerative Technologies (OTCQB:ORTIF) announced Friday a private placement offering of C$3M units priced at C$0.30 each. The company said proceeds will be used for the ORTHO-R Phase I/II US Clinical trial, and general corporate purposes. Each unit comprises of 1 common share and 1 sha...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES $3 MILLION NON-BROKERED PRIVATE PLACEMENT OF UNITS Canada NewsWire MONTREAL , Feb. 11, 2022 /CNW Telbec/ - Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (" Ortho " or the " Company "), a clinic...
ORTHO REGENERATIVE TECHNOLOGIES ENTERS INTO A MATERIAL TRANSFER AGREEMENT WITH A GLOBAL STRATEGIC MEDICAL COMPANY FOR ITS ORTHO-R ROTATOR CUFF TEAR REPAIR PHASE I/II U.S. CLINICAL TRIAL Canada NewsWire MONTREAL , Feb. 7, 2022 /CNW/ - Ortho Regenerative Technolo...
Ortho Regenerative Technologies (OTCQB:ORTIF): Q3 GAAP EPS of -C$0.06. Press Release For further details see: Ortho Regenerative Technologies reports Q3 results
ORTHO REGENERATIVE TECHNOLOGIES REPORTS ITS THIRD QUARTER 2022 RESULTS Canada NewsWire FDA clears Investigational New Drug application for the ORTHO-R rotator cuff tear repair U.S. Phase I/II clinical trial $1.05 million non-brokered private placement clo...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES U.S. IND CLINICAL HOLD LIFTED BY THE FDA & CLEARANCE TO PROCEED WITH U.S. CLINICAL TRIAL. ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES U.S. IND CLINICAL HOLD LIFTED BY THE FDA & CLEARANCE TO PROCEED WITH U.S. CLINICAL TRIAL. Can...
ORTHO REGENERATIVE TECHNOLOGIES CLOSES NON-BROKERED $1.05 MILLION PRIVATE PLACEMENT Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE...
Ortho Regenerative Technologies Announces Filing of Response to Type A Meeting with FDA and Non-Brokered $1.5 Million Private Placement Canada NewsWire /NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION, DIRECTL...
Ortho Regenerative Technologies Announces Successful Type A Meeting With U.S. FDA on CMC Elements For Which More Information Was Required to Clear IND Clinical Hold PR Newswire Agreement reached with FDA on Elemental impurity testing using selected standard r...
Ortho Regenerative Technologies Reports Its Second Quarter 2022 Results Canada NewsWire Significant progress made towards securing IND approval for our Rotator Cuff repair Phase I/II trial Type A meeting with FDA scheduled on October 5, 2021 ...
News, Short Squeeze, Breakout and More Instantly...
Ortho Regenerative Technologies Inc Company Name:
ORTIF Stock Symbol:
OTCMKTS Market:
Ortho Regenerative Technologies Inc Website:
(NewsDirect) ChitogenX CEO Phil Deschamps joined Proactive's Natalie Stoberman with news of the company's latest federal grant and partnership deal with Polytechnique Montréal to expand the ORTHO- R platform in regenerative medicine. Deschamps said the company has obtained a $3,472,0...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES CORPORATE NAME CHANGE TO CHITOGENX Canada NewsWire New Name to better represent Company's proprietary technology platform expanded applications beyond orthopedics MONTREAL , Sept. 7, 2022 /CNW Telbec/ ...
ORTHO REGENERATIVE TECHNOLOGIES ANNOUNCES ENROLLMENT OF FIRST PATIENT IN ITS U.S. PHASE I/II ROTATOR CUFF TEAR REPAIR CLINICAL TRIAL Canada NewsWire First patient surgery completed; additional surgeries already scheduled 8 clinical centres now fully initi...